
Natural hexosaminoglycan heparin remains the most commonly prescribed anticoagulant in hospitalized patients. However its administration could induce side clinical events, including thrombocytopenia and bleeding. This explaines the need of development of alternative anticoagulant drugs based on modified heparin and polyanionic oligo- and polysaccharide derivatives, such as sulfated glucans, phosphomannans and fucoidans. Here we review the works on the synthesis of oligosaccharides related to low molecular weight hepain fragments and their derivatives, as well as oligosaccharides, which imitate parts of heparin chain responsible for biological activity. These works were aimed to develop the pharmaceutical preparations lacking ofheparin disadvantages.
Molecular Structure, Heparin, Molecular Mimicry, Anticoagulants, Mannans, Molecular Weight, Fibrinolytic Agents, Polysaccharides, Humans, Glucans, Glycosaminoglycans
Molecular Structure, Heparin, Molecular Mimicry, Anticoagulants, Mannans, Molecular Weight, Fibrinolytic Agents, Polysaccharides, Humans, Glucans, Glycosaminoglycans
| citations The total number of citations received by all articles of the researcher of interest. | 11 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
